92 related articles for article (PubMed ID: 16989775)
1. Expression of mouse Fbxw7 isoforms is regulated in a cell cycle- or p53-dependent manner.
Matsumoto A; Onoyama I; Nakayama KI
Biochem Biophys Res Commun; 2006 Nov; 350(1):114-9. PubMed ID: 16989775
[TBL] [Abstract][Full Text] [Related]
2. Fbxw7β resides in the endoplasmic reticulum membrane and protects cells from oxidative stress.
Matsumoto A; Tateishi Y; Onoyama I; Okita Y; Nakayama K; Nakayama KI
Cancer Sci; 2011 Apr; 102(4):749-55. PubMed ID: 21205095
[TBL] [Abstract][Full Text] [Related]
3. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.
Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A
Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.
Snijders AM; Liu Y; Su L; Huang Y; Mao JH
Oncotarget; 2015 Dec; 6(42):44794-805. PubMed ID: 26575021
[TBL] [Abstract][Full Text] [Related]
5. Complex regulation of cell-cycle inhibitors by Fbxw7 in mouse embryonic fibroblasts.
Masuda K; Ishikawa Y; Onoyama I; Unno M; de Alborán IM; Nakayama KI; Nakayama K
Oncogene; 2010 Mar; 29(12):1798-809. PubMed ID: 20023701
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of FBXW7 isoforms by various stress stimuli.
Sionov RV; Netzer E; Shaulian E
Cell Cycle; 2013 Nov; 12(22):3547-54. PubMed ID: 24091628
[TBL] [Abstract][Full Text] [Related]
7. Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7.
Ishikawa Y; Onoyama I; Nakayama KI; Nakayama K
Oncogene; 2008 Oct; 27(47):6164-74. PubMed ID: 18641686
[TBL] [Abstract][Full Text] [Related]
8. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
[TBL] [Abstract][Full Text] [Related]
9. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis.
Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI
J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302
[TBL] [Abstract][Full Text] [Related]
10. A widely used pan-isoform-FBXW7 antibody used in cell cycle studies does not detect FBXW7.
Ennis H; McDonald DM
Cell Cycle; 2023 Jun; 22(11):1380-1390. PubMed ID: 37183425
[TBL] [Abstract][Full Text] [Related]
11. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
[TBL] [Abstract][Full Text] [Related]
12. p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases.
Yokobori T; Mimori K; Iwatsuki M; Ishii H; Onoyama I; Fukagawa T; Kuwano H; Nakayama KI; Mori M
Cancer Res; 2009 May; 69(9):3788-94. PubMed ID: 19366810
[TBL] [Abstract][Full Text] [Related]
13. Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis.
Cao J; Ge MH; Ling ZQ
Medicine (Baltimore); 2016 Feb; 95(7):e2496. PubMed ID: 26886596
[TBL] [Abstract][Full Text] [Related]
14. [Cell cycle regulation by F-box protein Fbxw7].
Tsunematsu R
Fukuoka Igaku Zasshi; 2009 Apr; 100(4):87-94. PubMed ID: 19562935
[No Abstract] [Full Text] [Related]
15. Ex vivo maintenance of hematopoietic stem cells by quiescence induction through Fbxw7α overexpression.
Iriuchishima H; Takubo K; Matsuoka S; Onoyama I; Nakayama KI; Nojima Y; Suda T
Blood; 2011 Feb; 117(8):2373-7. PubMed ID: 21190997
[TBL] [Abstract][Full Text] [Related]
16. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL.
Matsuoka S; Oike Y; Onoyama I; Iwama A; Arai F; Takubo K; Mashimo Y; Oguro H; Nitta E; Ito K; Miyamoto K; Yoshiwara H; Hosokawa K; Nakamura Y; Gomei Y; Iwasaki H; Hayashi Y; Matsuzaki Y; Nakayama K; Ikeda Y; Hata A; Chiba S; Nakayama KI; Suda T
Genes Dev; 2008 Apr; 22(8):986-91. PubMed ID: 18367647
[TBL] [Abstract][Full Text] [Related]
17. Multiple novel alternative splicing forms of FBXW7α have a translational modulatory function and show specific alteration in human cancer.
Liu Y; Ren S; Castellanos-Martin A; Perez-Losada J; Kwon YW; Huang Y; Wang Z; Abad M; Cruz-Hernandez JJ; Rodriguez CA; Sun Y; Mao JH
PLoS One; 2012; 7(11):e49453. PubMed ID: 23166673
[TBL] [Abstract][Full Text] [Related]
18. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas.
Jen KY; Song IY; Banta KL; Wu D; Mao JH; Balmain A
Blood; 2012 Jan; 119(3):805-9. PubMed ID: 22117044
[TBL] [Abstract][Full Text] [Related]
19. The FBXW7 beta-form is suppressed in human glioma cells.
Gu Z; Inomata K; Ishizawa K; Horii A
Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation is not the major mechanism for inactivation of the FBXW7 beta-form in human gliomas.
Gu Z; Inomata K; Mitsui H; Horii A
Genes Genet Syst; 2008 Aug; 83(4):347-52. PubMed ID: 18931460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
